Trump expected to sign EO to reclassify marijuana as soon as Monday, CNBC says
Yahoo Finance · —
Auto-translated from English. Article & images courtesy of the source — we recommend reading the full original.
Cannabis stocks jumped on Friday following reports that President Donald Trump will significantly ease federal restrictions on marijuana, with an executive order seen as coming as soon as Monday, CNBC’s Alex Harring and Brandon Gomez report. Trump is expected to use an executive order to instruct federal agencies to reclassify marijuana as a less regulated Schedule III drug from a Schedule I, the Washington Post reported on Thursday. Such a move would allow cannabis companies to fall under different tax regulations and encourage investment. Axios reported the potential reclassification of pot, out of a group that includes heroin and into a lower tier of less dangerous drugs, such as steroids and Tylenol with codeine, would take place early next year. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), Canopy Growth (CGC), Cronos Group (CRON), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN) and Trulieve Cannabis (TCNNF).
Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Trump Trade: Trump aiming to reduce restrictions on marijuana
Roth Capital positive on ‘immediate upside’ from cannabis scheduling change
TLRY, ACB, CGC: Why Are Cannabis Stocks Up Today?
Trump aims to reduce restrictions on marijuana through executive order, WP says
Aurora Cannabis announces launch of Black Jelly in Poland
Disclosure & disclaimer: All information, scores, signals and trade plans on this site are produced by an automated algorithmic system and are based on technical and quantitative data only. They do not constitute investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional that accounts for your needs and circumstances. We are not investment advisors. Trading securities involves substantial risk, up to the loss of your entire investment; every decision and action is your sole responsibility. i-trade and its operators bear no liability for any direct or indirect damage arising from reliance on this information.